|
2005 Chair and Program Director's Retreat at Kiawah Island, South Carolina October 20-22, 2005

ATTENDEES Craig Thompson - Abramson Family Cancer Research Institute, University of Pennsylvania Jill Pelling - Northwestern University Kathleen Rundell - Northwestern University James Broach - Princeton University Amato Giaccia - Stanford University Edmund Lattime - The Cancer Institute of New Jersey David Helfman - University of Miami Channing Der - University of North Carolina, Chapel Hill Mark Nelson - University of Arizona Fan Hung - University of California, Irvine Frederick Domann - University of Iowa Dario Altieri - University of Massachusetts Medical School Yoji Shimizu - University of Minnesota Marie Hanigan - University of Oklahoma Dihua Yu - University of Texas Lynn Matrisian - Vanderbilt University Frank Torti and Steven Akman - Wake Forest University School of Medicine Sam Brooks and Robert Pauley - Wayne State University Robert Dickson - Georgetown University Chris Counter - Duke University Beverly Delidow - Marshall University Kenneth Wright - University of South Florida Ann Roman - Indiana University Susan Marriott - Baylor College of Medicine Maxine Linial - Fred Hutchinson Cancer Research Center Paul Lambert - McArdle Laboratory for Cancer Research David Eckstein - National Cancer Institute Alan Eastman - Dartmouth Medical School
AGENDA Thursday, October 20 Arrivals and Reception
Friday, October 21 9:00 - 9:30 Introductions and Strategy Session 9:30 – 10:15 Session I - Facilitators: Lynn Matrisian, Amato Giaccia; Scribes: James Broach, Maxine Linial, Channing Der: Round Table-Cancer Biology as an academic discipline in an academic medical center: How is Cancer Biology organized at various institutions? Can we learn from each other? What are the relationships of departments and programs to Cancer Centers? Cancer Biology departments and programs seem threatened at some institutions. What can be done to strengthen Cancer Biology programs? Increasing visibility within institutions nationally. Dual degree and interdisciplinary programs. 10:15 – 11:00 Session II - Facilitators: Steve Akman, Craig Thompson, Jill Pelling; Scribes: Yoji Shimizu, Susan Marriott, Kenneth Wright, Robert Dickson: Round Table-Curriculum for Ph.D. students in Cancer Biology – How is it different from training in other basic sciences? Is there a core of knowledge that can be defined? Post doc training programs. Keeping our curriculum current as the field changes. Student award at a national meeting-AACR? Trainee meeting? Can we make our training programs visible nationally? 11:15 – 12:00 Session III - Facilitators: Edmund Lattime, Chris Counter; Scribes: Samuel Brooks, Rick Domann, Dihua Yu, Beverly Delidow: Round Table-Funding for Cancer Biology training programs. Do combined admissions programs help or hinder Cancer Biology training programs? Strategies for student recruitment to Cancer Biology training programs. Measuring success and failure. Student alumni-what are they doing now? Their perceptions of strengths and weaknesses of their training. 12:00 – 12:30 David Eckstein, Ph.D. 3:00 – 3:45 Session IV - Facilitators: Dario Altieri, Robert Pauley; Scribes: Hung Fan, Ann Roman: Round Table-Translational training for Ph.D. students in Cancer Biology. How can it be fostered? Should it be fostered? What does it mean? Should there be exposure to clinical issues? If so, how should this be organized within the curriculum? Teaching of Cancer Biology to medical students. Who does it? Who should do it? 4:00 – 4:45 Session V - Facilitators: Paul Lambert, Mark Nelson, Alan Eastman; Scribes: Marie Hanigan, Kathleen Rundell: Round Table-Career development opportunities inside and outside a Cancer Biology curriculum. How can opportunities be managed for our students and how can such opportunities be parlayed into attracting top students? Can we do better at identifying careers for our students?
Saturday, October 22 9:00 – 10:45 Session VI - Do we need formal structure as other departmental chairs associations? Do we want to meet at regular intervals? Can we influence decisions and funds allocation at the NIH? Is Cancer Biology as a discipline invisible to the NCI? 11:00 – 11:45 Plans for next year 12:00 Dismiss
Meeting notes (Download .pdf document - requires Adobe Acrobat)
|